Topcare Nicotine

Product NDC: 36800-734
11-digit product format: 368000734
Labeler code: 36800
Product ID: 36800-734_cfed4776-31f3-4047-86af-67c2cb6fa16e
Type: HUMAN OTC DRUG
Nonproprietary name: Nicotine Polacrilex
Dosage form: LOZENGE
Route: ORAL
Labeler: Topco Associates LLC
Application: ANDA203690
Marketing category: ANDA
Marketing start: 2013-02-15
Substance: NICOTINE
Active strength: 2 mg/1
Pharmacologic classes: Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	36800-734	36800-734-04	D	Discontinued by firm		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A203690-001	NICOTINE POLACRILEX	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL			2012-10-09
A203690-002	NICOTINE POLACRILEX	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL			2012-10-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A203690-001	NICOTINE POLACRILEX	EQ 2MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A203690-002	NICOTINE POLACRILEX	EQ 4MG BASE	TROCHE/LOZENGE / ORAL	2012-10-09	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Topcare Nicotine
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
NICOTINE	2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6M3C89ZY6R	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
359817	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
17cf8f3d-6491-4cd8-a447-3c7533f76daf	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
36800-734-02	2026-01-29	C162847	48780-1	49896155-b61e-586f-e063-e6dba90add90	Topco Associates LLC. Nicotine Lozenge Drug Facts
36800-734-04	2026-01-29	C162847	48780-1	49896155-b61e-586f-e063-e6dba90add90	Topco Associates LLC. Nicotine Lozenge Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
36800-734-01	Topcare Nicotine	27 in 1 CONTAINER	LOZENGE	27	6
36800-734-02	Topcare Nicotine	3 in 1 CARTON	LOZENGE	3	6
36800-734-04	Topcare Nicotine	5 in 1 CARTON	LOZENGE	5	6
36800-734-04	Topcare Nicotine	27 in 1 CONTAINER	LOZENGE	27	6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
36800-734-02	EA - Each	36800-734	43df65ab-502c-4937-9586-f639f66d9ef6	1	2024-04-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
NICOTINE	ACTIVE INGREDIENT	6M3C89ZY6R	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
NICOTINE	ACTIVE MOIETY	6M3C89ZY6R	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
ACESULFAME POTASSIUM	INACTIVE INGREDIENT	23OV73Q5G9	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
CALCIUM POLYCARBOPHIL	INACTIVE INGREDIENT	8F049NKY49	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
POLACRILIN	INACTIVE INGREDIENT	RCZ785HI7S	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
POTASSIUM BICARBONATE	INACTIVE INGREDIENT	HM5Z15LEBN	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
SODIUM ALGINATE	INACTIVE INGREDIENT	C269C4G2ZQ	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
SODIUM CARBONATE	INACTIVE INGREDIENT	45P3261C7T	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
36800-734	TOPCARE NICOTINE (NICOTINE POLACRILEX) LOZENGE [TOPCO ASSOCIATES LLC]	5	Current NDC, Legacy NDC, 4 package rows	20211117_17cf8f3d-6491-4cd8-a447-3c7533f76daf.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 5 · 83 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CareOne Nicotine	NICOTINE POLACRILEX	American Sales Company	74ec6a60-eb3a-47d4-a11b-650b6418d37f	2026-04-14	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
up and up cherry ice nicotine	NICOTINE POLACRILEX	Target Corporation	99977d30-41ba-4237-920a-dbd5ad8fc380	2026-04-14	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine	NICOTINE POLACRILEX	CVS Pharmacy	65ceb67b-dc22-4f5f-bfce-d6e957835eb3	2026-04-13	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Good Sense Nicotine	NICOTINE POLACRILEX	L. Perrigo Company	1a7cfbdc-53cc-4cd2-86b2-6e27a7979abf	2026-04-08	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
good sense nicotine	NICOTINE POLACRILEX	L. Perrigo Company	1e2631b6-b99e-4345-840e-9ddd0873a421	2026-04-07	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
up and up mint mini nicotine	NICOTINE POLACRILEX	Target Corporation	b07f00fe-84da-4d1c-a57f-6579b9f3fb9d	2026-03-17	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
up and up nicotine mini mint	NICOTINE POLACRILEX	Target Corporation	43f9d241-3af1-46cb-abe9-8c25427472aa	2026-03-17	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Up and Up Mini Nicotine	NICOTINE POLACRILEX	Target Corporation	a15b247e-cf4f-4802-a6e4-24750ea3809b	2026-03-17	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine	NICOTINE POLACRILEX	H E B	b1a13942-1fad-40da-8664-f70574b950d7	2026-03-11	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine	NICOTINE	H E B	85e3a322-e1a2-4f8e-a616-b279ad1bcefe	2026-03-03	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine	NICOTINE	H E B	be4a13e4-9938-4223-bcc1-4f5d96972813	2026-03-03	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine	NICOTINE POLACRILEX	H E B	1fb02f5e-56af-47ef-a1bc-49a6d86cc70c	2026-03-03	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
BLIP	NICOTINE POLACRILEX	Blip Products, Inc.	291649cf-e5a6-4a98-9a9e-c499b55c37ae	2026-03-02	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
nicotine	NICOTINE POLACRILEX	Kroger Company	fd67cb75-509c-41d5-8a2c-6c5fc53bf513	2026-02-26	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Nicotine Mini	NICOTINE POLACRILEX	Kroger Company	965be729-d417-4ae6-a2a9-ed06c2287d42	2026-02-17	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Topcare Nicotine	NICOTINE POLACRILEX	Topco Associates LLC	9f2f06c3-4d9b-4c1a-85e3-26f021be5d7c	2026-02-16	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
Topcare Nicotine	NICOTINE POLACRILEX	Topco Associates LLC	17cf8f3d-6491-4cd8-a447-3c7533f76daf	2026-02-13	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690 ndc (product): 36800-734
Nicotine Mini	NICOTINE POLACRILEX	Kroger Company	756c6b45-704e-4684-96ba-4df3ef27552c	2026-02-12	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
mini nicotine	NICOTINE POLACRILEX	Meijer, Inc.	7354774e-6784-48cb-84aa-57bcc17828c0	2026-02-10	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690
members mark mini nicotine	NICOTINE POLACRILEX	Sam's West Inc	5d05f906-8447-43a1-9460-c6da3f3873c7	2026-02-06	Warnings	Exact identifier application applno (ANDA): 203690 application number: ANDA203690

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6M3C89ZY6R	NICOTINE	54-11-5	NICOTINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
359817	nicotine 2 MG Oral Lozenge	PSN	17cf8f3d-6491-4cd8-a447-3c7533f76daf	6
359817	nicotine 2 MG Oral Lozenge	SCD	17cf8f3d-6491-4cd8-a447-3c7533f76daf	6
359817	nicotine 2 MG (as nicotine polacrilex 11.1 MG) Oral Lozenge	SY	17cf8f3d-6491-4cd8-a447-3c7533f76daf	6
359817	nicotine 2 MG Troche	SY	17cf8f3d-6491-4cd8-a447-3c7533f76daf	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
36800-734-01	36800073401	27 in 1 CONTAINER						Historical
36800-734-02	36800073402	3 CONTAINER in 1 CARTON (36800-734-02) / 27 LOZENGE in 1 CONTAINER (36800-734-01)	3 container	2013-02-15	0000-00-00	No	No	Current
36800-734-04	36800073404	5 CONTAINER in 1 CARTON (36800-734-04) > 27 LOZENGE in 1 CONTAINER	5 container	2014-06-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Topco Associates LLC. Nicotine Lozenge Drug Facts	Topco Associates LLC	2026-02-13	HUMAN OTC DRUG LABEL	6